Additional precautionary preventative measures implemented at hospital
Drickus Maartens • April 15, 2020
Photo source: www.netcarehospitals.co.za
Netcare Kingsway Hospital moves swiftly in the wake of COVID-19 infection
Netcare today confirmed that its KZN regional team and the hospital management at Netcare Kingsway Hospital have responded swiftly to managing the COVID-19 exposure at the hospital, and have temporarily closed the hospital for new admissions.
According to Craig Murphy, regional director of Netcare, the origin of the exposure has been traced to a patient who was admitted to hospital via the emergency department on 4 April 2020 with a suspected stroke. Upon admission, the patient was risk assessed and screened for COVID-19 symptoms and exposure as per the Netcare protocol, which is aligned to the NICD guidelines. The patient did not exhibit any signs of the virus and on questioning his family, no symptoms or exposure risks were reported.
“During his hospitalisation, the patient was visited by his general practitioner on the evening of 7 April who mentioned to the treating specialist that he had recently treated him for flu like symptom on 1 April. The treating specialist requested a COVID-19 test as a precautionary measure even though the patient was still asymptomatic. At the same time, the patient was placed in isolation as a person under investigation (PUI). The test results of the patient came back on 8 April confirming that the patient had a COVID-19 infection.
An abundance of caution to contain the spread of the infection
“In addition to closing the hospital for new admissions until further notice, we have taken several other measures” says Murphy.
“We embarked on an extensive programme of contact tracing so as to identify all nurses, doctors, paramedics, support staff and contract service providers in the hospital who may have had contact with the patient in question. Healthcare and other workers who have been exposed to the patient were asked to home-quarantine and self-monitor. Most of the identified contacts have been tested for COVID-19, the remainder of the exposed persons will be tested in the next few days. All potentially exposed patients have also been tested.”
“All of these individuals – those working in the hospital as well as patients – who have undergone COVID-19 laboratory testing are regarded as persons under investigation (PUIs) and have been placed in isolation to contain the possible spread of the virus. All of our staff, as well as our patients, have been offered counselling and this support will be ongoing.
“The emergency department was closed for outpatients as of 14 April and emergency medical service providers were notified to divert emergencies to other emergency departments.
“The hospital management also promptly communicated the exposure to the doctors practising at the hospital and requested that they cancel consultations and conduct telemedicine or telephonic consultations where possible, or defer their consultations to a later date, in order to restrict access to the hospital.
“Management have taken the decision to close the radiology department at the hospital for any investigations of persons who are not admitted to the hospital until further notice.
“Netcare has employed the services of two independent infectious disease specialists and epidemiologists to assist in investigating this incident at Netcare Kingsway Hospital.
“A systematic deep cleaning and decontamination process was started immediately, including the deployment of an ultraviolet disinfecting robot which has proved highly effective in destroying viruses, bacteria and fungal spores in healthcare facilities. This process is expected to continue over the next days.
“We understand that these precautionary measures will cause concern and inconvenience to the community, especially those with family members or friends being cared for in the hospital, as well as our staff members, doctors and other persons working at our hospital and their families. However, we believe these measures are absolutely necessary to safeguard all patients and persons working at Netcare Kingsway Hospital. The management team are contacting the family members of patients who have been admitted to Kingsway to explain the situation to them.
COVID-19 cases at the hospital
“The National Department of Health is the authority that officially announces information on COVID-19 cases, and we are thus not in a position to provide specific information on the exposure at the hospital. We are working closely with the KZN Department of Health (KZN DoH) with regard to the situation at Netcare Kingsway Hospital. We will provide more specific details after meeting with the KZN DoH”, confirmed Murphy.
“All persons whose test results are still awaited are regarded as PUIs and are either in self-isolation or are being accommodated in isolation by Netcare until such time as their test results are known, after which a decision will be made regarding staff members as to their return to work or continued self-isolation.
“PUIs and confirmed COVID-19 patients in Netcare hospitals are separately isolated and cared for either in isolation rooms or isolation cubicles, with doctors and nurses wearing appropriate personal protective equipment specific to the risk associated with each individual each case, and following Netcare’s protocols to prevent the spread of the infection to other patients and others working in the hospital.
Challenges of COVID-19
Commenting on the development, Dr Anchen Laubscher, group medical director of Netcare said that two of the greatest challenges associated with COVID-19 are that those infected do not always show or have any of the symptoms, and the fact that the virus is highly infectious, notwithstanding the absence of any symptoms.
“Even in the presence of extensive and effective infection prevention measures, such as those in place within Netcare hospitals, any workplace or gathering of people poses a potential risk for infection. Unfortunately, it has been shown that COVID-19 can be transmitted by carriers before they show symptoms that can be screened for, and where one person is contagious, the virus can very quickly spread to others.
“For this reason, Netcare took the decision a number of weeks ago of suspending visiting and public entry to its hospitals except in specific exceptional circumstances and closed its in-hospital pharmacies’ retail services to the public as well as its coffee shops. Daily screening of all persons entering our premises is also continuing, and where indicated, testing is then done,” notes Dr Laubscher.
No cost spared to keep patients and healthcare workers safe
According to Dr Laubscher, Netcare is sparing no effort or cost to keep every person in its care, as well as staff and doctors, as safe as possible.
“Netcare has already spent R150 million to enhance the readiness of its ICU and high care facilities, including purchasing additional ventilators, and we are also deploying more ultraviolet disinfection robots and specialised air filters to ensure appropriate disinfection measures,” she notes.
She adds that Netcare has so far also spent R300 million on additional, appropriate personal protective equipment (PPE) to supplement its stocks for staff and healthcare colleagues to ensure their safety while they work in the front line combatting the pandemic.
“Staff members and doctors at Kingsway Hospital, and those at all other Netcare facilities, have all been provided with appropriate PPE on an ongoing basis. Our PPE policy includes a directive on the wearing of masks during the COVID-19 pandemic which is, in fact, more conservative in that it provides greater protection than the current recommendations and guidelines of two highly respected health organisations, namely the World Health Organization (WHO) and the National Institute for Communicable Diseases (NICD).
“We wish to reiterate again that no Netcare facility has ever expected of a staff member to work without appropriate PPE as that would be contrary to our values. Importantly, we have re-trained over 20 518 healthcare workers, other staff members and doctors on the appropriate and correct use of PPE, and compliance in this regard is being closely and continuously monitored,” concludes Dr Laubscher.
Colorectal cancer, one of the most prevalent yet preventable cancers, can develop in the colon or rectum, often starting as small polyps that can quietly become malignant if left unchecked. Dr Mpho Ramabulana, a colorectal surgeon and gastroenterologist at Netcare Akasia Hospital, underscores the life-saving power of vigilance and the importance of early detection.
Cardiologist Dr Robert Routier urges the public to check their personal risk factors regularly to help prevent or manage cardiovascular disease.
The physical strain pregnancy puts on an expectant mother’s body should not be underestimated. An obstetrician gynaecologist offers her insights for alleviating discomfort and promoting wellbeing with exercise and stretching throughout pregnancy.
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an urgent call for increased focus on skills development to address the escalating kidney disease crisis among children in South Africa.
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
From treating trauma injuries caused by wildlife, road accidents and sports, to heart attacks, stroke, or the sudden onset of other concerning medical symptoms – the emergency department at Netcare St Anne’s Hospital never sleeps.
As many as one in ten teenagers may self-harm, often in secret, concealing the scars or evidence of their injuries. As Teen Suicide Prevention Week approaches, Netcare Akeso is highlighting the often-hidden struggle of self-harm among young people.
